Omniome

San Diego, United States Founded: 2013 • Age: 13 yrs Acquired By PacBio
Genome sequencing platform is provided for clinical diagnostics.
Request Access

About Omniome

Omniome is a company based in San Diego (United States) founded in 2013 was acquired by PacBio in July 2021.. Omniome has raised $160.23 million across 7 funding rounds from investors including PacBio, Gates Foundation and Arch Venture Partners. The company has 164 employees as of December 31, 2022. Omniome operates in a competitive market with competitors including Nanopore, PacBio, Complete Genomics, QuantuMDx and Bionano, among others.

  • Headquarter San Diego, United States
  • Employees 164 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Omniome, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $160.23 M (USD)

    in 7 rounds

  • Latest Funding Round
    $60 M (USD), Series C

    Dec 10, 2019

  • Investors
    PacBio

    & 12 more

  • Employee Count
    164

    as on Dec 31, 2022

  • Acquired by
    PacBio

    (Jul 20, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Omniome
Headcount 500-1000
Employee Profiles 51
Board Members and Advisors 8
Employee Profiles
People
Christian Henry
CEO & President
People
Brett Atkins
General Counsel
People
Mark Van Oene
COO
People
Natalie Welch
Chief People Officer

Unlock access to complete

Board Members and Advisors
people
Lucy Shapiro
Director
people
David Botstein
Director
people
Randy Livingston
Director
people
John F. Milligan
Chairman

Unlock access to complete

Funding Insights of Omniome

Omniome has successfully raised a total of $160.23M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $60 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series C — $60.0M
  • First Round

    (22 May 2014)

  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2019 Amount Series C - Omniome Valuation Detong Capital
Feb, 2019 Amount Series B - Omniome Valuation

investors

Jul, 2018 Amount Series B - Omniome Valuation Decheng Capital , Hillhouse
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Omniome

Omniome has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include PacBio, Gates Foundation and Arch Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Venture capital firm focused on life science companies
Founded Year Domain Location
Venture capital firm focused on life science and technology sectors
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Omniome

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Omniome

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Omniome Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Omniome

Omniome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Complete Genomics, QuantuMDx and Bionano, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Nanopore-based electronic systems for single-molecule analysis are developed.
domain founded_year HQ Location
Instrument systems and software for single-molecule real-time sequencing are developed.
domain founded_year HQ Location
DNA sequencing platform for human genome analysis is developed.
domain founded_year HQ Location
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
domain founded_year HQ Location
Provider of genome analysis solutions to researchers and clinicians
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Omniome

Frequently Asked Questions about Omniome

When was Omniome founded?

Omniome was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Omniome located?

Omniome is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Who is the current CEO of Omniome?

Dave Mullarkey is the current CEO of Omniome.

Is Omniome a funded company?

Omniome is a funded company, having raised a total of $160.23M across 7 funding rounds to date. The company's 1st funding round was a Series B of $60M, raised on May 22, 2014.

How many employees does Omniome have?

As of Dec 31, 2022, the latest employee count at Omniome is 164.

What does Omniome do?

Omniome was founded in 2013 and is headquartered in San Diego, United States. The company operates in the biotechnology sector, offering a genome sequencing platform based on Sequencing By Binding (SBB) technology. This platform supports nucleotide and DNA matching for clinical samples, with applications in cancer diagnostics, single-cell sequencing, and analysis of genome regions susceptible to errors. Services are extended to various clinical sequencing needs.

Who are the top competitors of Omniome?

Omniome's top competitors include Nanopore, PacBio and Novogene Corporation.

Who are Omniome's investors?

Omniome has 13 investors. Key investors include PacBio, Gates Foundation, Arch Venture Partners, Detong Capital, and Decheng Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available